Results 1 to 10 of about 6,194 (165)

Comparative Prognosis of Fungal Balls Versus Invasive Pulmonary Mucormycosis [PDF]

Infection and Drug Resistance
Jiayu Wang,1– 4 Naishu Xie,1– 4 Rui Zhao,1– 4 Huihui Zeng,1– 4 Yan Chen1– 4 1Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Research Unit of ...
Wang J, Xie N, Zhao R, Zeng H, Chen Y
doaj   +2 more sources

A rare case of an immunocompetent patient with isolated pulmonary mucormycosis

IDCases, 2023
As one of the most lethal infections caused by fungi, pulmonary mucormycosis usually affects patients who are immunocompromised. Isolated pulmonary mucormycosis in immunocompetent patients is very rare.This report describes a 65-year-old immunocompetent ...
Hamidreza Rouientan, Abolfazl Gilani, Roham Sarmadian, Mohammad Rezaei zadeh Rukerd   +3 more
doaj   +3 more sources

Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis. [PDF]

Clin Respir J
PM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Bai Y, Wei M, Liu J, Chen X, Gu L, Guo Y.   +5 more
europepmc   +2 more sources

Pulmonary mucormycosis: A case report

IDCases, 2020
Mucormycosis is a rare fungal infection caused by Mucorales order fungi. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas, pulmonary mucormycosis is a rare manifestation in patients with ...
António Grilo Novais, Joana Capelo, Marta Costa, Mariana Conceição, Pedro Crespo, Luísa Mocho, Beatriz Leão, Luís Malheiro, Susana Silva, António Sarmento   +9 more
doaj   +3 more sources

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis

Medical Mycology Case Reports, 2018
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino, Argun D. Can, Tam T. Van, Michele N. Matthews, Scott G. Filler   +4 more
doaj   +3 more sources

Tracheal, laryngeal and pulmonary mucormycosis followed by organizing pneumonia in a patient with Adult Onset Still's Disease

Medical Mycology Case Reports, 2018
We report a case of tracheal, laryngeal and pulmonary mucormycosis in a patient receiving immunosuppressive medication for an autoinflammatory fever syndrome.
Fabian Leo, Michael Zeh, Annegret Prothmann, Oliver Kurzai, Sylke Kurz, Christian Grohé   +5 more
doaj   +3 more sources

Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response [PDF]

Frontiers in Immunology
IntroductionMucormycosis is one of the most life-threatening fungal infections with delayed diagnosis and limited antifungal treatments. The transcriptome and proteome of pulmonary mucormycosis have not been fully investigated.MethodsWe obtained lung ...
Jinjin Zhong, Xiaomin Cai, Yuchen Cai, Tingting Zhao, Die Hu, Chao Sun, Yueyan Ni, Yu Gu, Yu Gu, Xin Su, Xin Su   +10 more
doaj   +2 more sources

A case report of pulmonary mucormycosis

APIK Journal of Internal Medicine, 2020
Pulmonary mucormycosis is a relatively rare pulmonary fungal disease which is difficult to diagnose and lacks effective treatment. The present study reports that the case of a 57-year-old patient who was treated successfully for pulmonary mucormycosis in
Surajsingh Ravindra Taur, Suresh Harsoor, Channamma Goudagaon   +2 more
doaj   +3 more sources

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

Medical Mycology Case Reports, 2021
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Andre K. Johnson, Zeron Ghazarian, Kristina D. Cendrowski, Jon G. Persichino   +3 more
doaj   +3 more sources

Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis. [PDF]

PLoS ONE
BackgroundPulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes.
Junjun Wan, Teng Liu, Fang Li, Shaohua Xu   +3 more
doaj   +2 more sources